Share Transfer, Director/PDMR dealing and RPT

TruSpine Technologies PLC
17 June 2024
 

 

 

17 June 2024

TruSpine Technologies plc

("TruSpine" or the "Company")

 

Share Transfer Agreement, Director/PDMR dealing and Related Party Transaction

 

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, the Company together with Geoff Miller, Non-executive Chairman of the Company and a shareholder of the Company ("Shareholder") entered into an agreement, pursuant to which the Shareholder has agreed to transfer 1,500,000 ordinary shares at a price of 1.5 pence per share, for an aggregate consideration of £22,500, to Geoff Miller (the "Share Transfer Agreement").

 

Director/PDMR dealing

 

As Geoff Miller is the Company's Non-executive Chairman, the Share Transfer Agreement constitutes a director dealing. Following the transaction, Mr Miller will hold 14,111,828 ordinary shares in the Company, representing 9.22 per cent. of the Company's current issued share capital. In addition, Mr Miller holds £136,573 of the Company's Convertible Loan Notes as announced on 14 March 2024.

 

Related Party Transaction

 

The entering into the Share Transfer Agreement (the "Transaction") is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook, by virtue of the Company and Geoff Miller, Non-executive Chairman of the Company, being a party to the Share Transfer Agreement. The directors of TruSpine independent of the Transaction confirm that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of TruSpine are concerned.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

-END-

 

Enquiries:

                                                                                               

TruSpine Investor Hub 

https://investorhub.truspinetech.com

TruSpine Technologies Plc

Tel: +44 (0)20 7118 0852

Geoff Miller, Non-executive Chairman




Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti


Peterhouse Capital Limited (Broker & Financial Adviser)

 
Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey

 


Novus Communications (PR and IR)

Tel: +44 (0)1273 704 473

Alan Green / Jacqueline Briscoe

 J.Briscoe@novuscomms.com

 

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

1

Details of the person discharging managerial responsibilities

 

a)

Name:

Geoff Miller

2

Reason for the Notification

a)

Position/Status:

Director

 

b)

Initial notification/ Amendment:

Initial Notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

TruSpine Technologies Plc

 

b)

LEI:

213800HNZX9B1QZPB225

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 0.01 pence each

 

ISIN: GB00BMZCKL55

b)

Nature of the transaction:

Acquisition of shares

 

c)

Price(s) and Volume(s):

 

 

 

Price(s)

Volume(s)

£0.015

1,500,000

d)

Aggregated Information:

- Aggregated Volume

- Price

N/A

 

e)

Date of the Transaction:

17 June 2024

 

f)

Place of the Transaction:

London

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings